Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

JMKX003948 Ophthalmic Suspension with formulation 1% (15 mg/1.5 mL), 2% (30 mg/1.5 mL), 3% (45 mg/1.5 mL), 5% (75 mg/1.5 mL)

JMKX003948 Ophthalmic Suspension placebo